If you have any problems related to the accessibility of any content (or if you want to request that a specific publication be accessible), please contact us at email@example.com.
|Date of Issue||2017|
|Identifier (Citation)||Su, Y.-W., Liu, P.-H., Hsu, C.-Y., Lee, Y.-H., Hsia, C.-Y., Ho, S.-Y., … Huo, T.-I. (2017). Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective. PLOS ONE, 12(3), e0174333. doi:10.1371/journal.pone.0174333|
|Description||Background Diabetes mellitus (DM) is associated with higher incidence and poorer prognosis of hepatocellular carcinoma (HCC). The influence of DM on patient survival in different HCC stages is not known. Methods A prospective dataset of 3,182 HCC patients was collected between 2002 and 2014. Patients were divided into three groups according to BCLC stages (BCLC stage 0 and stage A, BCLC stage B, BCLC stage C and stage D). We compared the cumulative survival rate of diabetic and non-diabetic patients in different BCLC groups. The correlation between DM and overall survival was also analyzed by multivariate Cox regression model within each group. Results|
|Rights||Creative Commons Attribution 4.0 International|
|Title||Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective|
|Department||Department of Internal Medicine|
|Journal Title||PLoS ONE|